XML 47 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shared-Based Compensation
9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Shared-Based Compensation

Note 11. Shared-Based Compensation

During the three and nine month periods ended September 30, 2014 and 2013, approximately $661 and $1,948 in 2014 and $573 and $1,666 in 2013, respectively, of compensation expense was recognized in selling, general and administrative expense for all share-based awards. During the nine month period ended September 30, 2014, there were 98 share awards and 98 options awards to non-executive directors, officers and certain other key employees. During the nine month period ended September 30, 2013, there were 95 share awards and 354 options awards to non-executive directors, officers and certain other key employees.

The restricted shares granted during the nine month periods ended September 30, 2014 and 2013, vest pro-rata over three years. During the nine month periods ended September 30, 2014 and 2013, we incurred $951 and $606, respectively, in expense related to restricted stock. The fair value of the shares issued was determined by using the grant date closing price of our common stock.

We incurred $997 and $1,060 of stock option expense in the nine month periods ended September 30, 2014 and 2013, respectively. The fair value of our options cannot be determined by market value, as our options are not traded in an open market. Accordingly, the Black Scholes financial pricing model is utilized to estimate the fair value.

The following table provides a reconciliation of option activity for the nine month period ended September 30, 2014:

 

Options

   Shares (000)     Weighted-
Average
Exercise
Price
     Weighted-
Average
Remaining
Contractual

Term
     Aggregate
Intrinsic Value
($000)
 

Outstanding at January 1, 2014

     1,233      $ 10.65         

Granted

     98      $ 19.69         

Exercised

     (149   $ 10.67         

Forfeited or expired

     (8   $ 12.62         
  

 

 

         

Outstanding at September 30, 2014

     1,174      $ 11.29         6.3       $ 18,065 (1) 
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at September 30, 2014

     819      $ 10.88         5.2       $ 12,965 (1) 
  

 

 

   

 

 

    

 

 

    

 

 

 

 

(1)  The intrinsic value is the amount by which the market price of our stock was greater than the exercise price of any individual option grant at September 30, 2014.